These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6686789)

  • 1. Fibrinolytic activity in human tumor tissues.
    Yuen P; Kwaan HC
    Cancer Invest; 1983; 1(5):369-78. PubMed ID: 6686789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue plasminogen activator activity in prostatic cancer.
    Köller A; Kirchheimer J; Pflüger H; Binder BR
    Eur Urol; 1984; 10(6):389-94. PubMed ID: 6085049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor metastasis and the fibrinolytic system].
    Yamamura M; Yamamoto M
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1246-54. PubMed ID: 2730023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboplastic and fibrinolytic activities of V2 and V7 carcinomas of rabbit, with special reference to fibrin deposition and thrombus formation in the tumors.
    Kodama Y; Tanaka K
    Acta Pathol Jpn; 1978 Mar; 28(2):279-86. PubMed ID: 676749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolysis associated with human neoplasia: production of plasminogen activator by human tumours.
    Nagy B; Ban J; Brdar B
    Int J Cancer; 1977 May; 19(5):614-20. PubMed ID: 863542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolysis: the key to new pathogenetic mechanisms.
    Zorio E; Gilabert-Estellés J; España F; Ramón LA; Cosín R; Estellés A
    Curr Med Chem; 2008; 15(9):923-9. PubMed ID: 18473800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor growth and metastases in malignant disease. A review.
    Kwaan HC
    J Med; 1988; 19(3-4):179-91. PubMed ID: 3141546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolysis and antifibrinolytic drugs in the growth and spread of tumours.
    Peterson H
    Cancer Treat Rev; 1977 Sep; 4(3):213-7. PubMed ID: 589607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of detergents on the measurement of the fibrinolytic activity of plasminogen activators.
    Kruithof EK; Ransijn A; Bachmann F
    Thromb Res; 1982 Oct; 28(2):251-60. PubMed ID: 6891111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasminogen activation and regulation of fibrinolysis].
    Madoiwa S
    Nihon Rinsho; 2014 Jul; 72(7):1218-23. PubMed ID: 25163311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tissue plasminogen activator activity in early prostatic cancer and in bone metastases of prostatic cancer].
    Pflüger H; Kirchheimer J; Ritschl P; Köller A; Hienert G; Binder BR
    Wien Klin Wochenschr; 1984 Sep; 96(17):658-61. PubMed ID: 6083673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrinolysis modulators].
    Machovich R
    Orv Hetil; 2002 Mar; 143(11):541-5. PubMed ID: 12583322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activators in human xenografted oro-pharyngeal squamous cell carcinomas.
    Björlin G; Ljungnér H; Wennerberg J; Astedt B
    Acta Otolaryngol; 1987; 104(5-6):568-72. PubMed ID: 3434279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
    Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
    Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of plasminogen activators in alopecia areata.
    Lotti T; Teofoli P; Senesi C; Fedi AM; Bonan P; Palleschi GM; Panconesi E
    Int J Dermatol; 1991 Jan; 30(1):19-21. PubMed ID: 1899652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of plasminogen activator and inhibition of embryonic cell aggregation by cultured human normal and neoplastic cells.
    Phan Thu A; Popovic M
    Neoplasma; 1979; 26(6):663-75. PubMed ID: 575560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the fibrinolytic system.
    Robison AK; Collen D
    Cardiol Clin; 1987 Feb; 5(1):13-9. PubMed ID: 3103919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolytic activity and species of plasminogen activator in human tears.
    Hayashi K; Sueishi K
    Exp Eye Res; 1988 Feb; 46(2):131-7. PubMed ID: 3127227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.